期刊文献+

血液透析联合血液灌流治疗尿毒症脑病患者的效果及其对毒素清除水平、神经功能及血清神经因子的影响 被引量:3

Effect of hemodialysis combined with hemoperfusion in the treatment of patients with uremic encephalopathy and its influence on toxin removal level,nerve function and serum neural factors
原文传递
导出
摘要 目的探究血液透析联合血液灌流治疗尿毒症脑病(UE)患者的效果及其对毒素清除水平、神经功能及血清神经因子的影响。方法选取我院收治的107例UE患者,根据随机数字表法分组。对照组53例给予单纯血液透析(HD)治疗,观察组54例给予血液透析(HD)联合血液灌流(HP)治疗,对比两组患者疗效。结果治疗后观察组尿素氮(BUN)、血肌酐(Scr)、全段甲状旁腺激素(iPTH)、β2-微球蛋白(β2-MG)、神经功能缺损(NIHSS)和不良事件发生率均低于对照组,格拉斯哥昏迷评分(GCS)、脑源性神经营养因子(BDNF)、神经肽Y(NPY)和总有效率高于对照组(P<0.05)。结论HD联合HP可促进UE患者神经功能恢复,提高毒素清除水平,提升临床疗效,安全性高。 Objective To explore the effect of hemodialysis combined with hemoperfusion in the treatment of patients with uremic encephalopathy(UE)and its effect on toxin clearance,neurological function and serum neural factors.Methods A total of 107 UE patients in our department were selected and grouped according to the random number table method.53 cases in the control group were treated with hemodialysis(HD),and 54 cases in the observation group were treated with hemodialysis(HD)combined with hemoperfusion(HP).The treatment effect of two groups were compared.Results After treatment,the level of BUN,Scr,iPTH,β2-MG,NIHSS,and the incidence of adverse events in the observation group were lower than those in the control group,and the levels of GCS,BDNF,NPY and total effective rates in the observation group were higher than those in the control group(P<0.05).Conclusion HD combined with HP can promote the recovery of nerve function,promote the level of toxin removal,and further improve the clinical efficacy and safety of patients with UE.
作者 陈玉灵 申鹏 孙丹丹 Chen Yuling;Shen Peng;Sun Dandan(People’s Hospital of Hebi City,Hebi 458030,China)
出处 《国际移植与血液净化杂志》 2021年第3期19-22,共4页 International Journal of Transplantation and Hemopurification
关键词 血液透析 血液灌流 尿毒症脑病 Hemodialysis Hemoperfusion Uremic encephalopathy
作者简介 通信作者:陈玉灵,Email:xiezthb@163.com。
  • 相关文献

参考文献8

二级参考文献76

  • 1宁晓霞,师社会,邢亮,刘涛,张海英,胡海涛.BDNF、TrkB在大鼠海马CA_3区的表达及其与学习记忆的关系[J].陕西医学杂志,2008,37(9):1130-1132. 被引量:6
  • 2De Deyn PP , Vanholder R, Eloot S, et al. Guanidino compounds as uremic (neuro )toxins[J]. Semin Dial, 2009,22 (4) : 340-345.
  • 3Massry SG,Smogorzewski M. PTH-PTHrP receptor in chronic renal failure[J]. Nephrol Dial Transplant, 1998,13 Suppl 1 : 50-57.
  • 4Raskin NH, Fishman RA. Neurologic disorders in renal failure (first of two parts)[J]. N Engl J Med, 1976,294(3): 143-148.
  • 5Tajima Y , Mito Y , Yanai M, et al. Unusualbasal ganglialesionsin a diabetic uraemic patient proven to be demyelination: first pathological observation[J]. BMJ Case Rep,2012,2012.doi: 10.1l36Ibcr-2012-006522.
  • 6Baumgaertel MW , Kraemer M, Berlit P. Neurologic complications of acute and chronic renal disease[J]. Handb Clin Neurol ,2014,119 :383-393.
  • 7BathlaG, Hegde AN. MRI and CT appearances in metabolic encephalopathies due to systemic diseases in adults[J]. Clin Radiol ,2013 ,68 (6): 545-554.
  • 8Kang E , Jeon SJ ,Choi SS. Uremic encephalopathy with atypical magnetic resonance features on diffusion-weighted images[J]. Korean J Radiol, 2012, 13(6) :808-811.
  • 9Camara-Lemarroy CR,Flores-Cantu H,Gonzalez-Velazquez CD,et al. Bilateral cytotoxic edema of the centrum semiovale in uremic encephalopathy[J]. J Neurol Sci ,2014 ,345(112) :260-261.
  • 10Fong CS. Neurological complications in uremia[J]. Acta Neurol Taiwan, 2008,17 (2) :117-126.

共引文献87

同被引文献35

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部